Matched to your study's patient profile.
We map local physicians by specialty, NPI taxonomy, and practice type — so the letter goes to doctors who actually see the patients your trial is designed for.
TrialNotice maps every relevant physician near your site, writes letters built around your specific study and patient profile, and delivers them as part of a full outbound pipeline — mail, email, LinkedIn, and SDR — that runs until the right referrals come in.
Your study is not for everyone. Neither is the outreach. Most direct mail is generic — the same letter sent to a list with no connection to the recipient. TrialNotice works differently. We identify the specific physicians near your site who see the specific patients your study needs, then write a letter built entirely around that match.
We map local physicians by specialty, NPI taxonomy, and practice type — so the letter goes to doctors who actually see the patients your trial is designed for.
The letter explains your study's indication, the patient profile, your site's location, and exactly how the physician can refer. Not a template. Built for this study.
The letter is the opening move. Email, LinkedIn, and SDR follow-up run in sequence behind it — so the study stays visible until the right physician engages.
When a physician receives a letter that names their specialty, explains a study relevant to patients they already see, and tells them exactly what to do next — that is a different experience than bulk mail. That's the difference between direct mail and precision outreach.
TrialNotice does not treat mail as a standalone campaign. The letter is part of a coordinated physician outreach sequence.
We identify local physicians and practices that are relevant to the active study, patient profile, specialty, and enrollment geography.
The letter explains the study in plain, physician-relevant language, including what kind of patient may be a fit and how the practice can take the next step.
Each letter can carry a unique QR path so engagement is tied back to the recipient and can inform follow-up priority.
Email, LinkedIn, SDR calls, and social follow-up keep the study visible after the letter arrives.
Scans, replies, and interest signals can flow into the site’s CRM, CTMS, calendar, reporting, or coordinator workflow.
Direct mail is especially useful when the study needs local physician awareness, a clear referral path, and follow-up that can be tracked across channels.
Reach specialists near the enrollment site who may already see patients that match the study profile.
Introduce a study to local primary care practices when the patient profile may appear in general practice settings.
Create physician awareness around a new study or support an active study that needs more qualified referral activity.
Follow up with physicians who previously engaged, scanned, replied, or showed interest in related study opportunities.
Direct mail can help when it is targeted to relevant physicians, written around a specific study, tracked by recipient, and supported by follow-up through email, LinkedIn, SDR calls, or other channels.
Clinical trial letters can help make local physicians aware of an active study, explain the patient profile, and give the practice a simple way to request more information or refer potential patient interest.
QR-tracked direct mail helps a clinical trial site understand which physicians engaged with the study letter and gives the team a signal for follow-up prioritization.
Usually not. The strongest approach is a coordinated sequence where direct mail is supported by email, LinkedIn, SDR follow-up, reporting, and coordinator handoff.
TrialNotice helps clinical trial sites use direct mail, QR tracking, email, LinkedIn, and SDR follow-up to build a local physician referral pipeline.
Contact us now